Use of 81 vs 325mg of ASA in Treatment of BCVI

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

September 30, 2025

Conditions
Carotid Artery InjuriesTraumatic InjuryVertebral Artery Injury
Interventions
DRUG

Acetylsalicylic Acid

Patients will undergo CT imaging with the use of contrast for diagnosis of BCVI. Patients will be monitored for feasibility outcomes, as well as the development of stroke and bleeding complications.

Sponsors
All Listed Sponsors
collaborator

Western University

OTHER

lead

London Health Sciences Centre

OTHER